Summary
The pharmacokinetics of a single 2 mg IV dose of chlordesmethyldiazepam has been studied in 11 patients with renal failure on regular haemodialysis and in 11 age-matched healthy controls. The kinetics was also examined after a single 2 mg oral dose in 6 of the 11 renal failure patients.
After intravenous administration the kinetics of total chlordesmethyldiazepam in renal patients and controls were the same. The unbound fraction of the drug in renal patients was higher (5.5%) than in controls (2.9%). Correction for differences in protein binding revealed a reduced apparent volume of distribution (47 vs. 140 l · kg−1) and a reduced clearance (5.0 vs. 10.5 ml · min−1 · kg−1) in the patients. The systemic availability of oral chlordesmethyldiazepam was good (82%) despite a relatively slow absorption rate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agricola A, Mazzarino M, Agricola R, Urani R, Fresia P (1981) A double-blind crossover clinical trial of chlordesmethyldiazepam versus lorazepam in neurotic inpatients: activity on anxiety-depression symptoms. Clin Ther 4: 339–408
Bareggi SR, Nielsen NP, Leva S, Pirola R, Zecca L, Lorini M (1986) Age-related multiple-dose pharmacokinetics and anxiolytic effects of delorazepam (chlordesmethyldiazepam). Int J Clin Pharmacol Res 6: 309–314
Bareggi SR, Pirola R, Leva S, Zecca L (1986) Pharmacokinetics of chlordemethyldiazepam after single-dose oral administration. Eur J Drug Metab Pharmacokinet 11: 171–174
Bareggi SR, Truci G, Leva S, Zecca L, Pirola R, Smirne S (1988) Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humans. Eur J Clin Pharmacol 34: 109–112
Murray TG, Chiang ST, Koepke HH, Walker BR (1981) Renal disease, age, and oxazepam kinetics. Clin Pharmacol Ther 30: 805–809
Busch U, Molzahn M, Bozler G, Koss FW (1981) Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease. Arzneim Forsch 31: 1507–1511
Ochs HR, Greenblatt DJ, Klehr U (1984) Disposition of oxazepam in patients on maintenance hemodialysis. Klin Wochenschr 62: 765–767
Morrison G, Chiang ST, Koepke HH, Walker BR (1984) Effect of renal impairment and hemodialysis on lorazepam kinetics. Clin Pharmacol Ther 35: 646–652
Kampf D, Huempel M, Lerche M, Kessel M (1981) Effect of uremia and hemodialysis on lormetazepam disposition. Clin Pharmacol Ther 30: 77–85
Kroboth PD, Smith RB, Rault R, Silver MR, Sorkin MI, Puschett JB, Juhl RP (1985) Effects of endstage renal disease and aluminium hydroxide on temazepam kinetics. Clin Pharmacol Ther 37: 453–459
Kroboth PD, Smith RB, Rault R, Silver MR, Sorkin MI, Puschett JB, Juhl RP (1985) Effects of endstage renal disease and aluminium hydroxide on triazolam kinetics. Br J Clin Pharmacol 19: 839–842
Ochs HR, Greenblatt DJ, Labedzki L, Smith RB (1986) Alprazolam kinetics in patients with renal insufficiency. J Clin Psychopharmacol 6: 292–294
Vinik HR, Reves JG, Greenblatt DJ, Abernethy DR, Smith RB (1983) The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiol 59: 390–394
Ochs HR, Greenblatt DJ, Kaschell HJ, Klehr U, Divoll M, Abernethy DR (1981) Diazepam kinetics in patients with renal insufficiency or hyperthyroidism. Br J Clin Pharmacol 12: 829–832
Ochs HR, Rauh HW, Greenblatt DJ, Kaschell HJ (1984) Clorazepate dipotassium and diazepam in renal insufficiency: serum concentrations and protein binding of diazepam and desmethyldiazepam. Nephron 37: 100–104
Zecca L, Ferrario P, Pirola R, Bareggi SR (1987) Analysis of chlordesmethyldiazepam and its metabolites in plasma and urine. J Chromatogr Biol App 420: 417–424
Zysset T, Zeugin T (1986) Comparison of the Amicon Centrifree micropartition system with the Sartorius SM 13249E Centrisart I device to determine protein free phenytoin concentrations. Ther Drug Monit 8: 346–351
Gomeni R (1984): PHARM: An interactive graphic program for individual and population pharmacokinetic parameter estimation. Comp Biol Med 14, 25–34
Balogh A, Funfstuck R, Demme U, Kangas L, Sperschneider H, Traeger A, Stein G, Pekkarinen A (1981) Dialysability of benzodiazepines by hemodialysis and controlled sequential filtration (CSU) in vitro. Acta Pharmacol Toxicol 49: 174–180
Greenblatt DJ, Murray TG, Audet PR, Locniskar A, Koepke HH, Walker BR (1983) Multiple-dose kinetics and dialysability of oxazepam in renal insufficiency. Nephron 34: 234–238
Gambertoglio JG: Effects of renal disease: altered pharmacokinetics. In: LZ Benet, N Massoud and JG Gambertoglio: Pharmacokinetic basis for drug treatment. Raven Press, N.Y., 149–171, 1984
Abel JG, Sellers EM, Naranjo CA, Shaw J, Kadar D, Romach MK (1979) Inter- and intrasubject variation in diazepam free fraction. Clin Pharmacol Ther 216: 247–255
Reidenberg MM (1977) The biotransformation of drugs in renal failure. Am J Med 62: 482–485
Bareggi SR, Pirola R, Truci G, Leva S, Smirne S (1988) Effect of food on absorption of chlordesmethyldiazepam. Arzneim Forsch 38: 561–562
Shader RI, Georgotas A, Greenblatt DJ, Harmatz JS, Allen MD (1978) Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide. Clin Pharmacol Ther 24: 308–315
Greenblatt DJ, Shader RJ, Harmatz JS, Franke K, Koch-Weser J (1976) Influence of magnesium and aluminum hydroxide mixture on chordiazepoxide absorption. Clin Pharmacol Ther 19: 234–239
Greenblatt DJ, Allen MD, MacLaughlin DS, Harmatz JS, Shader RI (1978) Diazepam absorption: effect of antacids and food. Clin Pharmacol Ther 24: 600–609
Divoll M, Greenblatt DJ, Ciraulo DA, Puri SK, Ho I, Shader RJ (1982) Clobazam kinetics: intrasubject variability and effect of food on absorption. J Clin Pharmacol 22: 69–73
Greenblatt DJ, Shader RI, Harmatz JS, Franke K, Koch-Weser J (1977) Absorption rate, blood concentrations and early response to oral chlordiazepoxide. Am J Psychiat 137: 559–562
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sennesael, J., Verbeelen, D., Vanhaelst, L. et al. Pharmacokinetics of intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis. Eur J Clin Pharmacol 41, 65–68 (1991). https://doi.org/10.1007/BF00280109
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280109